Gene · 5216
Papers2,319
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,319
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nuclear Actin Polymerization Regulates Cell Epithelial-Mesenchymal Transition. | Adv Sci (Weinh) | 2023 | 37566765 | PubTator, text mining | PubMed |
| Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy. | Cells | 2023 | 37566027 | PubTator, text mining | PubMed |
| Proteomic profiling of the brain from the wobbler mouse model of amyotrophic lateral sclerosis reveals elevated levels of the astrogliosis marker glial fibrillary acidic protein. | Eur J Transl Myol | 2023 | 37565261 | PubTator, text mining | PubMed |
| How neurons maintain their axons long-term: an integrated view of axon biology and pathology. | Front Neurosci | 2023 | 37564364 | PubTator, text mining | PubMed |
| Functional genomics in stem cell models: considerations and applications. | Front Cell Dev Biol | 2023 | 37554308 | PubTator, text mining | PubMed |
| Spatially resolved protein map of intact human cytomegalovirus virions. | Nat Microbiol | 2023 | 37550507 | PubTator, text mining | PubMed |
| Serum proteomic identification and validation of two novel atherosclerotic aortic aneurysm biomarkers, profilin 1 and complement factor D. | Proteome Sci | 2023 | 37543598 | PubTator, text mining | PubMed |
| Differential Expression of miRNAs in Amyotrophic Lateral Sclerosis Patients. | Mol Neurobiol | 2023 | 37531027 | PubTator, text mining | PubMed |
| miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer. | Genes (Basel) | 2023 | 37510280 | PubTator, text mining | PubMed |
| Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review. | Diagnostics (Basel) | 2023 | 37510072 | PubTator, text mining | PubMed |
| Identification of Gene Markers Associated with COVID-19 Severity and Recovery in Different Immune Cell Subtypes. | Biology (Basel) | 2023 | 37508378 | PubTator, text mining | PubMed |
| Identifying the Common Cell-Free DNA Biomarkers across Seven Major Cancer Types. | Biology (Basel) | 2023 | 37508365 | PubTator, text mining | PubMed |
| Small extracellular vesicles-transported lncRNA TDRKH-AS1 derived from AOPPs-treated trophoblasts initiates endothelial cells pyroptosis through PDIA4/DDIT4 axis in preeclampsia. | J Transl Med | 2023 | 37488572 | PubTator, text mining | PubMed |
| Bankable human iPSC-derived retinal progenitors represent a valuable source of multipotent cells. | Commun Biol | 2023 | 37479765 | PubTator, text mining | PubMed |
| Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk. | J Exp Clin Cancer Res | 2023 | 37464436 | PubTator, text mining | PubMed |
| Exploring biomarkers of premature ovarian insufficiency based on oxford nanopore transcriptional profile and machine learning. | Sci Rep | 2023 | 37460774 | PubTator, text mining | PubMed |
| Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer. | J Biol Chem | 2023 | 37451478 | PubTator, text mining | PubMed |
| Review Insights on Salivary Proteomics Biomarkers in Oral Cancer Detection and Diagnosis. | Molecules | 2023 | 37446943 | PubTator, text mining | PubMed |
| Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2023 | 37445986 | PubTator, text mining | PubMed |
| Actin Cytoskeleton Polymerization and Focal Adhesion as Important Factors in the Pathomechanism and Potential Targets of Mucopolysaccharidosis Treatment. | Cells | 2023 | 37443816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5216/papers?page=11